Datameds Ai earnings were -$76.6M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest MEDS earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$7.7M, down 72.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MEDS reported annual earnings of -$101.3M, with 1,377.1% growth. The next MEDS earnings date is Aug 18, 2026.
Datameds Ai (NASDAQ: MEDS) reported Q1 2026 earnings per share (EPS) of -$3.50, up 88.71% year over year. Total MEDS earnings for the quarter were -$7.74 million. In the same quarter last year, Datameds Ai's earnings per share (EPS) was -$31.00.
The next MEDS earnings call is Aug 18, 2026. Add MEDS to your watchlist to be reminded of Datameds Ai's next earnings date.
What was MEDS's earnings growth in the past year?
As of Datameds Ai's earnings date in Q3 2026, Datameds Ai's earnings has grown year over year. MEDS earnings in the past year totalled -$76.59 million.
Is Datameds Ai profitable or losing money?
As of the last Datameds Ai earnings report, Datameds Ai is currently losing money. Datameds Ai's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$76.59 million, a 95.35% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.